Equities

Sosei Group Corp

Sosei Group Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)1,621.00
  • Today's Change19.00 / 1.19%
  • Shares traded990.70k
  • 1 Year change-26.85%
  • Beta0.8547
Data delayed at least 20 minutes, as of Mar 28 2024 06:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sosei Group Corporation is a holding company primarily engaged in the biopharmaceutical business. The pharmaceutical business is engaged in the research, development and sales of medicines, the management of regenerative medical funds, the investment in bio venture companies related to regenerative medicine, the overseas development by licensing, the promotion of commercialization, the structural analysis of GPCR, the initial lead compound creation, the candidate search by proprietary StaR technology, as well as structural base of new drugs using GPCR related basic technology drug discovery, screening, promotion of antibody drug research and development.

  • Revenue in JPY (TTM)12.77bn
  • Net income in JPY-7.19bn
  • Incorporated1990
  • Employees202.00
  • Location
    Sosei Group Corp11F, PMO Hanzomon, 2-1, Koji-machiCHIYODA-KU 102-0083JapanJPN
  • Phone+81 352103290
  • Fax+81 352103291
  • Websitehttps://soseiheptares.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
4565:TYO since
announced
Transaction
value
Idorsia Pharmaceuticals Korea Co LtdDeal completed20 Jul 202320 Jul 2023Deal completed9.31%135.00k
Idorsia Pharmaceuticals Japan LtdDeal completed20 Jul 202320 Jul 2023Deal completed9.31%51.72m
Idorsia Ltd-Ex-China APAC/Japan Pharmaceuticals businessDeal completed20 Jul 202320 Jul 2023Deal completed9.31%465.98m
Data delayed at least 20 minutes, as of Mar 28 2024 06:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ispace Inc1.99bn-2.52bn72.18bn216.00--19.55--36.24-33.88-33.8824.7644.550.1476--24.879,219,852.00-18.66---32.11--46.91---126.42--1.72-16.860.7317--46.74---180.75------
Eiken Chemical Co Ltd39.90bn2.95bn80.60bn754.0025.541.4915.392.0278.8378.831,067.991,355.090.60132.743.0752,923,080.004.448.835.4511.3442.6746.397.3812.162.95--0.056331.240.63964.34-7.7517.070.621615.33
JCR Pharmaceuticals Co Ltd41.37bn5.36bn113.09bn879.0020.381.9613.812.7342.7842.78330.47445.940.42530.54923.0347,059,160.005.539.638.3814.6774.8374.3412.9919.321.1519.240.29427.35-32.7710.77-74.004.2053.6725.21
Zeria Pharmaceutical Co Ltd74.57bn8.64bn115.75bn1.73k11.121.227.441.55195.97195.971,691.651,780.160.5141.443.3743,130,530.005.963.379.315.4073.9071.4511.606.520.8269--0.391541.3314.871.1556.418.305.403.30
Takara Bio Inc47.67bn1.57bn118.61bn1.79k75.501.0618.092.4913.0513.05395.88932.120.37951.472.5826,586,730.001.2711.781.3813.3655.3263.903.3420.225.81--0.0024.1315.4319.32-19.3346.9729.8756.32
Torii Pharmaceutical Co Ltd54.64bn4.12bn119.09bn563.0028.210.967426.012.18146.56146.561,944.224,274.440.40913.032.13--3.086.523.417.3545.3749.557.5417.986.19--0.00224.1811.74-2.674.4428.76-20.3820.11
Kyorin Pharmaceutical Co Ltd119.83bn4.26bn119.98bn2.14k25.020.842814.171.0074.2374.232,089.342,203.280.6781.342.7356,047,710.002.413.203.123.9342.9248.723.565.101.40--0.14170.577.330.47120.12-6.4019.42-2.16
Mochida Pharmaceutical Co Ltd100.09bn3.01bn123.28bn1.53k39.010.91921.381.2384.3484.342,768.283,579.890.62941.862.9165,457,820.001.894.862.265.9451.2452.203.017.363.24--0.0041.96-6.28-0.6644-37.09-5.9214.62-1.21
Sosei Group Corp12.77bn-7.19bn143.29bn202.00--2.14--11.22-87.73-87.73154.90746.930.0995--3.39---5.61-0.6588-6.11-0.703675.7089.83-56.34-4.463.62-8.250.5254---18.00---1,982.98------
GNI Group Ltd26.01bn8.09bn148.87bn701.0018.654.4014.725.72160.06160.06531.67678.010.54021.787.33--19.747.2322.658.7886.2485.7536.5414.573.6726.420.09310.0049.3238.971,981.71--19.69--
Towa Pharmaceutical Co Ltd236.78bn11.74bn154.34bn4.30k12.570.99094.830.6518238.42238.424,810.523,023.620.61341.623.7355,090,510.003.044.733.806.3934.6641.274.968.061.48--0.568619.9726.1117.46-86.17-19.4614.6613.63
Sumitomo Pharma Co Ltd330.31bn-173.72bn160.35bn6.25k--0.466--0.4855-437.26-437.26831.40864.730.27171.362.7152,849,120.00-14.951.15-22.201.6759.9372.18-55.042.540.3785--0.545241.44-0.80193.54-232.08--0.62043.13
KAKEN PHARMACEUTICAL CO., LTD.72.10bn2.97bn164.74bn1.13k45.890.969128.822.2978.1478.141,915.493,700.490.4291.862.8963,801,770.001.768.172.009.5653.8955.554.1116.094.68--0.026744.04-4.01-5.81-43.03-22.173.160.00
Kissei Pharmaceutical Co Ltd73.72bn12.20bn175.55bn1.80k13.360.805110.612.38266.51266.511,612.294,421.720.32131.682.6041,067,970.005.383.215.873.4748.2352.3916.7411.104.51--0.00736.563.23-1.83-18.523.083.7410.76
Peptidream Inc28.71bn3.04bn182.79bn569.0060.014.5233.426.3723.4323.43221.37311.320.43074.522.66--4.55--5.34--59.97--10.57--2.882.800.3551--6.93---59.81------
Data as of Mar 28 2024. Currency figures normalised to Sosei Group Corp's reporting currency: Japanese Yen JPY

Institutional shareholders

24.48%Per cent of shares held by top holders
HolderShares% Held
Taiyo Pacific Partners LPas of 11 Jan 20246.37m7.12%
Nomura Asset Management Co., Ltd.as of 29 Dec 20233.07m3.43%
The Vanguard Group, Inc.as of 07 Mar 20242.58m2.89%
Capital Research & Management Co. (World Investors)as of 15 Feb 20241.84m2.06%
Asset Management One Co., Ltd.as of 15 Dec 20231.72m1.92%
Mitsubishi UFJ Asset Management Co., Ltd.as of 08 Mar 20241.51m1.69%
Capital International KKas of 15 Feb 20241.35m1.51%
JPMorgan Asset Management (Japan) Ltd.as of 15 Jun 20231.30m1.46%
Ichiyoshi Asset Management Co., Ltd.as of 19 Dec 20221.18m1.32%
BlackRock Fund Advisorsas of 07 Mar 2024981.40k1.10%
More ▼
Data from 19 Dec 2022 - 22 Feb 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.